Mayo, MJ, Wigg, AJ, Roberts, SK, Arnold, H, Hassanein, TI, Leggett, BA, Bate, JP, Weltman, M, Carey, EJ, Muir, AJ, McCaughan, G, Bollipo, SJ, Gordon, SC, Angus, PW, Riordan, S, Shiffman, ML, Young, E, Ling, L, Luo, J, Elliott, M, Rossi, S, DePaoli, AM, and Thompson, AJ. "NGM282, A Novel Variant of FGF-19, Demonstrates Biologic Activity in Primary Biliary Cirrhosis Patients with an Incomplete Response to Ursodeoxycholic Acid: Results of a Phase 2 Multicenter, Randomized, Double Blinded, Placebo Controlled Trial." 66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). San Francisco, CA. November 13, 2015 - November 17, 2015.: WILEY-BLACKWELL, October 1, 2015.